CORRECTED-UPDATE 3-Roche’s combo lymphoma treatment wins U.S. FDA approval

The U.S. Food and Drug Administration on
Monday granted earlier-than-expected approval to Roche Holding
AG’s antibody- Polivy for treatment of patients
with advanced lymphoma.

JEFFREY LIPTON in BARBADOS – http://feeds.reuters.com/~r/reuters/companyNews/~3/4LCtReguOjI/corrected-update-3-roches-combo-lymphoma-treatment-wins-u-s-fda-approval-idUSL4N23H390